Herpes virus strains for gene therapy

• 收藏
• 分享

专利权人:

BIOVEX LIMITED

发明人:

申请号：

BE2016C033

公开号：

BE2016C033I2

申请日:

2016.06.14

申请国别(地区):

BE

年份:

2020

代理人:

摘要：

The present invention relates to the use of a modified, oncolytic, herpes simplex virus (HSV) strain in the manufacture of a medicament for the oncolytic treatment of cancer, which HSV strain: (a) has a greater ability than HSV1 17+, HSV1 F and HSV1 KOS strains with equivalent modifications to replicate in or kill tumour cells； and (b) is obtainable by isolating an HSV strain from a host and modifying the isolated HSV strain to provide for selective replication in tumour cells. <；IMAGE>；

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/